{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-029326","form_type":"8-K","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2026-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.090864+00:00","generated_at":"2026-05-16T06:49:58.392695+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ResMed Q2 FY2026: Revenue $1.42B (+11% YoY), non-GAAP EPS $2.81, dividend $0.60","bullets":["Revenue $1,422.8M, up 11% YoY (9% constant currency); gross margin expanded 320 bps to 61.8%.","GAAP diluted EPS $2.68; non-GAAP diluted EPS $2.81, up 16% YoY.","Operating cash flow $340M; income from operations rose 18% YoY.","Board declared quarterly cash dividend of $0.60/share, record Feb 12, payable Mar 19."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-029326","json":"https://secwatch.observer/filing/0001193125-26-029326.json","markdown":"https://secwatch.observer/filing/0001193125-26-029326.md","text":"https://secwatch.observer/filing/0001193125-26-029326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312526029326/0001193125-26-029326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312526029326/d80310d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:49:58.392695+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}